These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4946079)

  • 1. Distribution and mechanism of clearance of L-asparaginase (NSC-109229).
    Ho DH; Carter CJ; Thetford B; Frei E
    Cancer Chemother Rep; 1971 Dec; 55(5):539-45. PubMed ID: 4946079
    [No Abstract]   [Full Text] [Related]  

  • 2. The partitioning of L-asparaginase between blood and lymph.
    Hall JG
    Recent Results Cancer Res; 1970; 33():75-80. PubMed ID: 4949170
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of canine serum asparagine levels by L -asparaginase immobilized on collagen: a potential form of cancer chemotherapy.
    Olanoff LS; Bernath FR; Venkatasubramanian K; Joyeuse R
    Trans Am Soc Artif Intern Organs; 1975; 21():156-64. PubMed ID: 807012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229).
    Haskell CM; Canellos GP; Cooney DA; Hardesty CT
    Cancer Chemother Rep; 1972 Oct; 56(5):611-4. PubMed ID: 4569055
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enzyme changes in pancreatic venous blood and in lymph from the thoracic duct after short-term block of the duct, venostasis and ischaemia of the pancreas in the dog (author's transl)].
    Bartos V; Nozicková M
    Cesk Gastroenterol Vyz; 1980; 34(8):512-6. PubMed ID: 6162575
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasoactive substances and reticuloendothelial function.
    Blattberg B; Levy MN
    Am J Physiol; 1966 Mar; 210(3):569-72. PubMed ID: 5933207
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of the iso-electric point of L-asparaginase upon its persistence in the blood.
    Rutter DA; Wade HE
    Br J Exp Pathol; 1971 Dec; 52(6):610-4. PubMed ID: 4944363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
    J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased antitumor activity of Escherichia coli. L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y; Wada H; Yagura T; Nishimura H; Matsushima A; Inada Y
    Gan; 1982 Jun; 73(3):470-4. PubMed ID: 6751921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the seromucoid and haptoglobin level in serum by the reticuloendothelial system.
    Ohara H; Nishio H; Watanabe K; Wada T
    J Reticuloendothel Soc; 1972 Apr; 11(4):301-12. PubMed ID: 4554294
    [No Abstract]   [Full Text] [Related]  

  • 11. A simple and rapid method for the estimation of L-asparaginase in chromatographic and electrophoretic effluents: comparison with other methods.
    Jayaram HN; Cooney DA; Jayaram S; Rosenblum L
    Anal Biochem; 1974 Jun; 59(2):327-46. PubMed ID: 4599360
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical modifications of Escherichia coli L-asparaginase and their effect on plasma clearance rate and other properties.
    Nickle EC; Solomon RD; Torchia TE; Wriston JC
    Biochim Biophys Acta; 1982 Jun; 704(2):345-52. PubMed ID: 7049249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dacron wool packed-bed extracorporeal reactor: a kinetic study of immobilized Escherichia coli II L-asparaginase.
    KO RY; Hersh LS
    J Biomed Mater Res; 1976 Mar; 10(2):249-58. PubMed ID: 3508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody sandwich enzyme-linked immunoadsorbent assay for determination of recombinant E. coli L-asparaginase in rat plasma and its pharmacokinetics].
    Chen JH; Wu WT; Kazuyuki H
    Yao Xue Xue Bao; 2003 Aug; 38(8):613-6. PubMed ID: 14628454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical modification of E. coli L-asparaginase by N,O-carboxymethyl chitosan.
    Qian G; Zhou J; Ma J; Wang D; He B
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):567-77. PubMed ID: 8922226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
    Broome JD
    Br J Cancer; 1968 Sep; 22(3):595-602. PubMed ID: 4878639
    [No Abstract]   [Full Text] [Related]  

  • 17. The distribution and clearance of L-asparaginase.
    Schwartz MK
    Recent Results Cancer Res; 1970; 33():58-63. PubMed ID: 5526348
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of RES activity and circulatory responsiveness in the dog.
    Kampine JP; Banaszak EF; Smith JJ
    J Reticuloendothel Soc; 1965 Jul; 2(2):172-86. PubMed ID: 5856690
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of asparagine, aspartate, glutamine, and glutamate in lymphoid tissue: basis for immunosuppression by L-asparaginase.
    Prager MD; Derr I
    J Immunol; 1971 Apr; 106(4):975-9. PubMed ID: 5553721
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of stimulants and depressants of reticuloendothelial activity on drug metabolism.
    Wooles WR; Munson AE
    J Reticuloendothel Soc; 1971 Feb; 9(2):108-19. PubMed ID: 4404947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.